Medibio Limited (MDBIF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -848.31 Thousand | -932.08 Thousand | -1.65 Million | -1.69 Million | -3.58 Million | -6.8 Million |
| Net Income | -1.23 Million | -3.07 Million | -12.71 Million | -1.48 Million | -3.87 Million | -6.58 Million |
| Depreciation & Amortization | 93.13 Thousand | 541.03 Thousand | 383.66 Thousand | 198.51 Thousand | 148.86 Thousand | - |
| Deferred income taxes | - | -41.56 Thousand | 32.92 Thousand | -785.83 Thousand | -625.02 Thousand | - |
| Stock-based compensation | - | 41.56 Thousand | -32.92 Thousand | 785.83 Thousand | 625.02 Thousand | 2.38 Million |
| Change in working capital | - | 237.76 Thousand | 669.84 Thousand | -665.59 Thousand | -468.67 Thousand | -1.14 Million |
| Other non-cash items | 481.91 Thousand | 1.31 Million | 10.03 Million | -531.7 Thousand | -14.06 Thousand | -1.45 Million |
| Investing Cash Flow | -2.5 Million | -2.25 Million | -3.1 Million | -1.83 Million | -1.5 Million | -1.08 Million |
| Investments in PPE | -2.5 Million | -2.25 Million | -3.1 Million | -1.83 Million | -1.54 Million | -1.13 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 28.95 Thousand | - |
| Other Investing Activities | -2.5 Million | -2.25 Million | 3.00 | 1330.00 | 7562.00 | 54.01 Thousand |
| Financing Cash Flow | 4.6 Million | 2.46 Million | 3.33 Million | 4.92 Million | 4.55 Million | 3.12 Million |
| Debt repayment | -5500.00 | -40 Thousand | -89.2 Thousand | -52.09 Thousand | -154.62 Thousand | -2.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -140.87 Thousand |
| Common Stock Issuance | 4.7 Million | 2.5 Million | 3.37 Million | 4.97 Million | 4.7 Million | 923.46 Thousand |
| Other Financing Activities | -94.57 Thousand | -40 Thousand | -44.95 Thousand | -52.09 Thousand | -154.62 Thousand | 4.68 Million |
| Accounts receivables | - | - | 24.28 Thousand | 349.00 | -17.63 Thousand | 1.65 Million |
| Accounts payables | - | 262.77 Thousand | 386.18 Thousand | -443.42 Thousand | -604.16 Thousand | -1.86 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | -25 Thousand | 259.38 Thousand | -222.52 Thousand | 153.11 Thousand | -937.35 Thousand |
| Cash at beginning of period | 214.11 Thousand | 1.03 Million | 2.31 Million | 812.5 Thousand | 1.33 Million | 6.12 Million |
| Cash at end of period | 848.09 Thousand | 214.11 Thousand | 1.03 Million | 2.31 Million | 812.5 Thousand | 1.33 Million |
| Capital Expenditure | -2.5 Million | -2.25 Million | -3.1 Million | -1.83 Million | -1.54 Million | -1.13 Million |
| Effect of forex changes on cash | 2158.00 | -95.11 Thousand | 156.45 Thousand | 109.74 Thousand | 19.15 Thousand | -26.18 Thousand |
| Net cash flow / Change in cash | 633.98 Thousand | -818.45 Thousand | -1.27 Million | 1.49 Million | -520.58 Thousand | -4.79 Million |
| Free Cash Flow | -3.34 Million | -3.19 Million | -4.76 Million | -3.53 Million | -5.12 Million | -7.94 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -151.59 Thousand | -1.23 Million | -1.08 Million | -542.75 Thousand | -3.07 Million | -2.64 Million |
| Depreciation & Amortization | 46.35 Thousand | 93.13 Thousand | 46.78 Thousand | 23.39 Thousand | 541.03 Thousand | 274.46 Thousand |
| Deferred income taxes | - | - | - | - | -41.56 Thousand | -557.2 Thousand |
| Stock-based compensation | - | - | - | - | 41.56 Thousand | 20.78 Thousand |
| Change in working capital | - | - | - | - | 237.76 Thousand | -12.5 Thousand |
| Other non-cash items | 811.75 Thousand | 481.91 Thousand | -329.83 Thousand | -212.83 Thousand | 1.31 Million | 2.46 Million |
| Investing Cash Flow | -1.49 Million | -2.84 Million | -1.35 Million | -674.81 Thousand | -2.25 Million | -1.3 Million |
| Investments in PPE | -1.49 Million | -2.84 Million | -1.35 Million | - | -2.25 Million | -1.3 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -674.81 Thousand | -674.81 Thousand | -2.25 Million | -654.88 Thousand |
| Financing Cash Flow | 1.4 Million | 4.32 Million | 2.91 Million | 1.45 Million | 2.46 Million | 1.73 Million |
| Debt repayment | -5500.00 | -5500.00 | - | - | -40 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.48 Million | 4.45 Million | 2.96 Million | - | 2.5 Million | 1.72 Million |
| Other Financing Activities | - | - | 1.45 Million | 1.45 Million | -40 Thousand | 865.63 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | 262.77 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | -25 Thousand | -12.5 Thousand |
| Cash at beginning of period | 310.82 Thousand | 214.11 Thousand | 214.11 Thousand | - | 1.03 Million | 317.9 Thousand |
| Cash at end of period | 848.09 Thousand | 848.09 Thousand | 310.82 Thousand | 48.35 Thousand | 214.11 Thousand | 214.11 Thousand |
| Capital Expenditure | -1.49 Million | -2.84 Million | -1.35 Million | - | -2.25 Million | -1.3 Million |
| Effect of forex changes on cash | - | - | -1320.00 | -1320.00 | -95.11 Thousand | -31.69 Thousand |
| Net cash flow / Change in cash | 537.27 Thousand | 633.98 Thousand | 96.7 Thousand | 48.35 Thousand | -818.45 Thousand | -103.79 Thousand |
| Free Cash Flow | -882.9 Thousand | -3.69 Million | -2.81 Million | -732.19 Thousand | -3.19 Million | -1.77 Million |
TAKE
BLUEDART
PICCASUG
TIINDIA
SAHYADRI
WFG